About
Representation
View all Representation →Consultations- Digitisation Taskforce – Final Report
- FCA Consults on Fund Product Information and Cost Disclosure CP24/30 – ShareSoc Responds
- FRC Consults on UK Stewardship Code – ShareSoc Responds
- FCA Consultation – Modernising Redress
- HMRC Consultation – IHT on Pensions
- ShareSoc Evidence to Lords on FCA Enforcement
- ShareSoc supports FCA proposal for criminal background checks on owners and controllers of financial institutions
- UK ISA: ShareSoc submits consultation response
- FCA Consultation on Enforcement Practice & Transparency
- ShareSoc response to House of Commons Education Select Committee
- UKSA and ShareSoc Submission to Labour Party Review of Financial Services
- FCA Consultation GC23/2 Financial Promotions on Social Media
- VIEW ALL CONSULTATIONS
Education
Events
- Forums
Company
4D PHARMA PLC (DDDD)
Blog posts
Financial Ombudsman and FCA considered lacking, plus defective Insolvency Regime
Post Date: September 5, 2022
The views expressed in this article are those of its author and not necessarily those of ShareSoc.
The stock markets are in turmoil now everyone is back from their holidays and facing up to the realisation that with high inflation and looming recessions the stock market may not be the best place to be for investors. I have moved more into cash and more defensive shares but cash is not the place to be for very long when inflation is eroding its ...
DDDD – 4D Pharma placing with no Primary Bid individual offer
Post Date: April 19, 2021
By Cliff Weight, ShareSoc Director. I hold shares in DDDD.
I am not sure if I am happy or angry with 4D Pharma. Duncan Peyton (Chief Executive Officer) and Alex Stevenson (Chief Scientific Officer) have each subscribed £725,000 for shares in the placing, which in total raised £20m at a price of 110p. Their commitment and increased skin in the game is excellent and praiseworthy.
The share price this morning is 118p. So those who invested at 110p have a modest gain of 7%.
However ...
A Review of my Portfolio in 2020
Post Date: January 23, 2021
By Cliff Weight, ShareSoc Director
Please note I am not qualified to give investment advice, and nothing in this blog constitutes advice.
Overview
Chris Spencer Phillips reported in a recent blog https://www.sharesoc.org/blog/investment-strategies/a-review-of-my-2020-share-portfolio-chris-spencer-phillips/ that his portfolio was up +80% in 2020, after being + 25% in 2019. Congrats and hats off to Chris. I cannot rival that, but I thought readers might find my review of 2020 of interest.
My portfolio numbers for 2020 were:
Everything – all equities, ISAs, SIPPs, OEICS, etc ...
Leaders and Laggards
DDDD – 4D Pharma placing with no Primary Bid individual offer
Post Date: April 19, 2021
By Cliff Weight, ShareSoc Director. I hold shares in DDDD.
I am not sure if I am happy or angry with 4D Pharma. Duncan Peyton (Chief Executive Officer) and Alex Stevenson (Chief Scientific Officer) have each subscribed £725,000 for shares in the placing, which in total raised £20m at a price of 110p. Their commitment and increased skin in the game is excellent and praiseworthy.
The share price this morning is 118p. So those who invested at 110p have a modest gain of 7%.
However ...
Become a free Associate ShareSoc member
Enter your email to sign up as a free Associate ShareSoc member and receive our emails. It takes a few seconds — and on the next page you'll have the option to customise your membership.